In addition, inhibition of cholic acid synthesis by CYP8B1 deficiency inhibits dyslipidemia and atherosclerosis in ApoE−/− mice by decreasing intestinal lipid absorption [26], suggesting that cholic acid deficiency is caused by the lipid-lowering and anti-atherogenic effects of INT-767. This evidence concerns the gene CYP8B1 and metabolic syndrome.